autologous natural killer cell therapy (Guangzhou Doublle Bioproducts)

N/A

Report date: 2025/03/14 16:32:45

Base Information

Drug Nameautologous natural killer cell therapy (Guangzhou Doublle Bioproducts)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Dabo Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Dabo Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A